Literature DB >> 19581346

Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice.

Sayuri Hoshi1, Nobuo Hoshi, Minoru Okamoto, Jorge Paiz, Takashi Kusakabe, Jerrold M Ward, Shioko Kimura.   

Abstract

NKX2-1 is a homeodomain transcription factor that is critical for genesis of the thyroid and transcription of the thyroid-specific genes. Nkx2-1-thyroid-conditional hypomorphic mice were previously developed in which Nkx2-1 gene expression is lost in 50% of the thyroid cells. Using this mouse line as compared with wild-type and Nkx2-1 heterozygous mice, a thyroid carcinogenesis study was carried out using the genotoxic carcinogen N-bis(2-hydroxypropyl)-nitrosamine (DHPN), followed by sulfadimethoxine (SDM) or the non-genotoxic carcinogen amitrole (3-amino-1,2,4-triazole). A significantly higher incidence of adenomas was obtained in Nkx2-1-thyroid-conditional hypomorphic mice as compared with the other two groups of mice only when they were treated with DHPN + SDM, but not amitrole. A bromodeoxyuridine incorporation study revealed that thyroids of the Nkx2-1-thyroid-conditional hypomorphic mice had >2-fold higher constitutive cell proliferation rate than the other two groups of mice, suggesting that this may be at least partially responsible for the increased incidence of adenoma in this mouse line after genotoxic carcinogen exposure. Thus, NKX2-1 may function to control the proliferation of thyroid follicular cells following damage by a genotoxic carcinogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581346      PMCID: PMC2736302          DOI: 10.1093/carcin/bgp167

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  39 in total

1.  Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action.

Authors:  K Yasuhara; T Koujitani; K Takegawa; M Nasu; H Onodera; H Takagi; M Hirose; K Mitsumori
Journal:  Carcinogenesis       Date:  2001-04       Impact factor: 4.944

2.  Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.

Authors:  Song Xue; Clive Wasserfall; Matthew Parker; Sean McGrail; Kieran McGrail; Martha Campbell-Thompson; Desmond A Schatz; Mark A Atkinson; Michael J Haller
Journal:  J Diabetes Complications       Date:  2009-02-13       Impact factor: 2.852

3.  Specific pattern of RAS oncogene mutations in follicular thyroid tumors.

Authors:  V Vasko; M Ferrand; J Di Cristofaro; P Carayon; J F Henry; C de Micco
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

4.  Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation.

Authors:  Toshio Imai; Jun-ichi Onose; Mai Hasumura; Makoto Ueda; Tamotsu Takizawa; Masao Hirose
Journal:  Toxicol Pathol       Date:  2004 Mar-Apr       Impact factor: 1.902

5.  Thyrocyte-specific expression of Cre recombinase in transgenic mice.

Authors:  Takashi Kusakabe; Akio Kawaguchi; Rumi Kawaguchi; Lionel Feigenbaum; Shioko Kimura
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

6.  Effect of dose on the carcinogenic activity of orally administered N-bis(2-hydroxypropyl)nitrosamine in rats.

Authors:  Y Konishi; H Kondo; T Ikeda; A Kawabata; Y Shoji; A Denda
Journal:  Gan       Date:  1978-08

7.  Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN).

Authors:  H Y Son; A Nishikawa; T Ikeda; H Nakamura; M Miyauchi; T Imazawa; F Furukawa; M Hirose
Journal:  Jpn J Cancer Res       Date:  2000-09

8.  Dose- and sex-related carcinogenesis by N-bis(2-hydroxypropyl)nitrosamine in Wistar rats.

Authors:  E L Moreira; J L de Camargo; M A Rodrigues; L F Barbisan; D M Salvadori
Journal:  Jpn J Cancer Res       Date:  2000-04

Review 9.  Thyroid development and its disorders: genetics and molecular mechanisms.

Authors:  Mario De Felice; Roberto Di Lauro
Journal:  Endocr Rev       Date:  2004-10       Impact factor: 19.871

Review 10.  A unique combination of transcription factors controls differentiation of thyroid cells.

Authors:  G Damante; G Tell; R Di Lauro
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001
View more
  8 in total

1.  Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?

Authors:  Lizhe Ai; Yaqin Yu; Xiaoli Liu; Chong Wang; Jieping Shi; Hui Sun; Qiong Yu
Journal:  Front Med       Date:  2014-01-23       Impact factor: 4.592

2.  Elevated HMGN4 expression potentiates thyroid tumorigenesis.

Authors:  Jamie Kugler; Yuri V Postnikov; Takashi Furusawa; Shioko Kimura; Michael Bustin
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

3.  Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.

Authors:  Yutaka Maeda; Tomoshi Tsuchiya; Haiping Hao; David H Tompkins; Yan Xu; Michael L Mucenski; Lingling Du; Angela R Keiser; Takuya Fukazawa; Yoshio Naomoto; Takeshi Nagayasu; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

4.  Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

Authors:  Eric L Snyder; Hideo Watanabe; Margaret Magendantz; Sebastian Hoersch; Tiffany A Chen; Diana G Wang; Denise Crowley; Charles A Whittaker; Matthew Meyerson; Shioko Kimura; Tyler Jacks
Journal:  Mol Cell       Date:  2013-03-21       Impact factor: 17.970

Review 5.  The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities.

Authors:  David Mu
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

6.  Thyroid-specific transcription factors and their roles in thyroid cancer.

Authors:  Shioko Kimura
Journal:  J Thyroid Res       Date:  2011-04-28

7.  An in vivo model for thyroid regeneration and folliculogenesis.

Authors:  Manabu Iwadate; Yoshinori Takizawa; Yo-Taro Shirai; Shioko Kimura
Journal:  Lab Invest       Date:  2018-06-26       Impact factor: 5.662

8.  NKX2-1 re-expression induces cell death through apoptosis and necrosis in dedifferentiated thyroid carcinoma cells.

Authors:  Yuko Ito; Fumihiko Furuya; Katsumi Taki; Hideaki Suzuki; Hiroki Shimura
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.